Insider · CIK 0001242882

GOLD MITCHELL

Reports to the SEC for 3 companies · SAN CARLOS, CA

sec.gov

Transactions

Companies

Filings

CIK

0001242882

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-08-04	ATTOAttovia Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+27K sh	—	—	27,000
2024-05-20	ALPINE IMMUNE SCIENCES, INC.Stock Option (Right to buy)D Disposition to Issuer	Director, Executive Chairman and CEO	DDisposition to Issuer	−200K sh	—	—	0
2024-05-20	ALPINE IMMUNE SCIENCES, INC.D Disposition to Issuer	Director, Executive Chairman and CEO	DDisposition to Issuer	−96K sh	—	—	0
2024-05-20	ALPINE IMMUNE SCIENCES, INC.Stock Option (Right to buy)D Disposition to Issuer	Director, Executive Chairman and CEO	DDisposition to Issuer	−255K sh	—	—	0
2024-05-20	ALPINE IMMUNE SCIENCES, INC.Stock Option (Right to buy)D Disposition to Issuer	Director, Executive Chairman and CEO	DDisposition to Issuer	−70K sh	—	—	0
2024-05-20	ALPINE IMMUNE SCIENCES, INC.Stock Option (Right to buy)D Disposition to Issuer	Director, Executive Chairman and CEO	DDisposition to Issuer	−209K sh	—	—	0
2024-05-20	ALPINE IMMUNE SCIENCES, INC.Stock Option (Right to buy)D Disposition to Issuer	Director, Executive Chairman and CEO	DDisposition to Issuer	−215K sh	—	—	0
2024-05-20	ALPINE IMMUNE SCIENCES, INC.Stock Option (Right to buy)D Disposition to Issuer	Director, Executive Chairman and CEO	DDisposition to Issuer	−270K sh	—	—	0
2024-05-20	ALPINE IMMUNE SCIENCES, INC.Stock Option (Right to buy)D Disposition to Issuer	Director, Executive Chairman and CEO	DDisposition to Issuer	−248K sh	—	—	0
2024-05-20	ALPINE IMMUNE SCIENCES, INC.D Disposition to Issuer	Director, Executive Chairman and CEO	DDisposition to Issuer	−13.2K sh	—	—	96,000
2024-05-20	ALPINE IMMUNE SCIENCES, INC.Stock Option (Right to buy)D Disposition to Issuer	Director, Executive Chairman and CEO	DDisposition to Issuer	−240K sh	—	—	0
2024-05-20	ALPINE IMMUNE SCIENCES, INC.Stock Option (Right to buy)D Disposition to Issuer	Director, Executive Chairman and CEO	DDisposition to Issuer	−337K sh	—	—	0
2024-05-18	ALPINE IMMUNE SCIENCES, INC.U Disposition from Tender	Director, Executive Chairman and CEO	UDisposition from Tender	−2.63M sh	—	—	0
2024-05-08	ALPINE IMMUNE SCIENCES, INC.M Exercise/Conversion	Director, Executive Chairman and CEO	MExercise/Conversion	+13.2K sh	$7.55	+$100K	109,245
2024-05-08	ALPINE IMMUNE SCIENCES, INC.Stock Option (Right to buy)M Exercise/Conversion	Director, Executive Chairman and CEO	MExercise/Conversion	−13.2K sh	—	—	336,755
2024-01-04	ALPINE IMMUNE SCIENCES, INC.A Award	Director, Executive Chairman and CEO	AAward	+96K sh	—	—	96,000
2024-01-04	ALPINE IMMUNE SCIENCES, INC.Stock Option (Right to buy)A Award	Director, Executive Chairman and CEO	AAward	+240K sh	—	—	240,000
2023-12-28	ALPINE IMMUNE SCIENCES, INC.M Exercise/Conversion	Director, Executive Chairman and CEO	MExercise/Conversion	+1,016 sh	$0.65	+$660.4	1,016
2023-12-28	ALPINE IMMUNE SCIENCES, INC.Warrant (right to buy)M Exercise/Conversion	Director, Executive Chairman and CEO	MExercise/Conversion	−74.4K sh	—	—	0
2023-12-28	ALPINE IMMUNE SCIENCES, INC.M Exercise/Conversion	Director, Executive Chairman and CEO	MExercise/Conversion	+74.4K sh	$12.74	+$948K	2,675,421
2023-12-28	ALPINE IMMUNE SCIENCES, INC.Stock Option (Right to buy)M Exercise/Conversion	Director, Executive Chairman and CEO	MExercise/Conversion	−1,016 sh	—	—	247,951
2023-12-28	ALPINE IMMUNE SCIENCES, INC.F Tax Payment	Director, Executive Chairman and CEO	FTax Payment	−48.3K sh	$19.65	−$948K	2,627,157
2023-12-28	ALPINE IMMUNE SCIENCES, INC.S Sale	Director, Executive Chairman and CEO	SSale	−1,016 sh	$20.04	−$20.4K	0
2023-12-27	ALPINE IMMUNE SCIENCES, INC.Stock Option (Right to buy)M Exercise/Conversion	Director, Executive Chairman and CEO	MExercise/Conversion	−29.6K sh	—	—	248,967
2023-12-27	ALPINE IMMUNE SCIENCES, INC.M Exercise/Conversion	Director, Executive Chairman and CEO	MExercise/Conversion	+29.6K sh	$0.65	+$19.2K	29,573
2023-12-27	ALPINE IMMUNE SCIENCES, INC.S Sale	Director, Executive Chairman and CEO	SSale	−29.6K sh	$20.04	−$593K	0
2023-12-26	ALPINE IMMUNE SCIENCES, INC.M Exercise/Conversion	Director, Executive Chairman and CEO	MExercise/Conversion	+2,402 sh	$0.45	+$1,080.9	2,402
2023-12-26	ALPINE IMMUNE SCIENCES, INC.Stock Option (Right to buy)M Exercise/Conversion	Director, Executive Chairman and CEO	MExercise/Conversion	−2,402 sh	—	—	0
2023-12-26	ALPINE IMMUNE SCIENCES, INC.Stock Option (Right to buy)M Exercise/Conversion	Director, Executive Chairman and CEO	MExercise/Conversion	−22.1K sh	—	—	278,540
2023-12-26	ALPINE IMMUNE SCIENCES, INC.S Sale	Director, Executive Chairman and CEO	SSale	−24.5K sh	$20.22	−$495K	0
2023-12-26	ALPINE IMMUNE SCIENCES, INC.M Exercise/Conversion	Director, Executive Chairman and CEO	MExercise/Conversion	+22.1K sh	$0.65	+$14.4K	24,486
2023-12-22	ALPINE IMMUNE SCIENCES, INC.M Exercise/Conversion	Director, Executive Chairman and CEO	MExercise/Conversion	+37.8K sh	$0.45	+$17K	37,825
2023-12-22	ALPINE IMMUNE SCIENCES, INC.Stock Option (Right to buy)M Exercise/Conversion	Director, Executive Chairman and CEO	MExercise/Conversion	−37.8K sh	—	—	2,402
2023-12-22	ALPINE IMMUNE SCIENCES, INC.S Sale	Director, Executive Chairman and CEO	SSale	−37.8K sh	$20.43	−$773K	0
2023-12-19	ALPINE IMMUNE SCIENCES, INC.Stock Option (Right to buy)M Exercise/Conversion	Director, Executive Chairman and CEO	MExercise/Conversion	−2,402 sh	—	—	40,227
2023-12-19	ALPINE IMMUNE SCIENCES, INC.S Sale	Director, Executive Chairman and CEO	SSale	−2,402 sh	$20.01	−$48.1K	0
2023-12-19	ALPINE IMMUNE SCIENCES, INC.M Exercise/Conversion	Director, Executive Chairman and CEO	MExercise/Conversion	+2,402 sh	$0.45	+$1,080.9	2,402
2023-12-12	ALPINE IMMUNE SCIENCES, INC.S Sale	Director, Executive Chairman and CEO	SSale	−32.5K sh	$17.32	−$562K	0
2023-12-12	ALPINE IMMUNE SCIENCES, INC.M Exercise/Conversion	Director, Executive Chairman and CEO	MExercise/Conversion	+8,613 sh	$0.45	+$3,875.85	8,613
2023-12-12	ALPINE IMMUNE SCIENCES, INC.Stock Option (Right to buy)M Exercise/Conversion	Director, Executive Chairman and CEO	MExercise/Conversion	−8,613 sh	—	—	42,629
2023-12-12	ALPINE IMMUNE SCIENCES, INC.S Sale	Director, Executive Chairman and CEO	SSale	−8,613 sh	$17.32	−$149K	0
2023-12-11	ALPINE IMMUNE SCIENCES, INC.S Sale	Director, Executive Chairman and CEO	SSale	−68.9K sh	$17.26	−$1.19M	32,450
2023-12-08	ALPINE IMMUNE SCIENCES, INC.S Sale	Director, Executive Chairman and CEO	SSale	−8,067 sh	$17.08	−$138K	101,320
2023-01-04	ALPINE IMMUNE SCIENCES, INC.Stock Option (Right to buy)A Award	Director, Executive Chairman and CEO	AAward	+350K sh	—	—	350,000
2022-01-04	ALPINE IMMUNE SCIENCES, INC.Stock Option (Right to buy)A Award	Director, Executive Chairman and CEO	AAward	+215K sh	—	—	215,000
2021-09-17	ALPINE IMMUNE SCIENCES, INC.S Sale	Director, Executive Chairman and CEO	SSale	−45.3K sh	$10.01	−$453K	109,387
2021-09-17	ALPINE IMMUNE SCIENCES, INC.S Sale	Director, Executive Chairman and CEO	SSale	−400K sh	$9.40	−$3.76M	2,600,980
2021-09-16	ALPINE IMMUNE SCIENCES, INC.S Sale	Director, Executive Chairman and CEO	SSale	−6,768 sh	$10.00	−$67.7K	154,649
2021-09-15	ALPINE IMMUNE SCIENCES, INC.S Sale	Director, Executive Chairman and CEO	SSale	−3,484 sh	$10.00	−$34.8K	161,417
2021-06-28	ALPINE IMMUNE SCIENCES, INC.S Sale	Director, Executive Chairman and CEO	SSale	−3,479 sh	$10.00	−$34.8K	164,901

Recent filings

Accepted (ET)
Aug 64
GOLD MITCHELL0001242882-26-000004
SEC(opens sec.gov)
May 204
GOLD MITCHELL0001626199-24-000092
SEC(opens sec.gov)
May 104
GOLD MITCHELL0001626199-24-000073
SEC(opens sec.gov)
Jan 54
GOLD MITCHELL0001626199-24-000025
SEC(opens sec.gov)
Dec 294
GOLD MITCHELL0001626199-23-000149
SEC(opens sec.gov)

Companies

Address

C/O ATTOVIA THERAPEUTICS, INC. 1091 INDUSTRIAL ROAD, SUITE 310

SAN CARLOS, CA, 94070